Cells from a subset of patients with the DNArepair-defective disease xeroderma pigmentosum complementation group E (XP-E) are known to lack a DNA damagebinding (DDB) activity. Purified human DDB protein was injected into XP-E cells to test whether the DNA-repair defect in these cells is caused by a defect in DDB activity. Injected DDB protein stimulated DNA repair to normal levels in those strains that lack the DDB activity but did not stimulate repair in cells from other xeroderma pigmentosum groups or in XP-E cells that contain the activity. These results provide direct evidence that defective DDB activity causes the repair defect in a subset of XP-E patients, which in turn establishes a role for this activity in nucleotide-excision repair in vivo.
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Ddb+ and Ddb-to indicate the phenotypes of cell culture strains that contain or lack DDB activity, respectively. The designation Ddb+ is not intended to imply that the DDB protein present in some XP-E cells is absolutely like wild type but to imply only that DDB activity can be detected in normal amounts in extracts from these strains.] Moreover, demonstration of a correlation between a defect in DDB activity and the XP-E disease neither proves a causal relationship nor confirms a role for the DDB protein in DNA repair. To directly address these issues, we examined the ability of purified DDB protein to correct the DNA-repair defect in XP-E cells.
The cancer-prone genetic disease xeroderma pigmentosum (XP) is characterized by clinical and cellular hypersensitivity to UV radiation, correlated with a defect in nucleotideexcision repair of damaged DNA (for review, see ref. 1). On the basis ofcell-fusion studies, XP patients have been divided into seven excision-repair-defective complementation groups (A-G) (as well as the excision-repair-proficient variant group V). Elucidating the molecular bases of the repair defects in these groups is an important step in understanding the mechanisms by which human cells defend against potentially toxic or mutagenic DNA damage. Chu and Chang (2) reported that cells from two consanguineous XP-E patients lack a DNA damage-binding (DDB) activity that recognizes UV-irradiated DNA. The DDB protein has recently been purified to apparent homogeneity and characterized from human placenta and from HeLa cells (3) (4) (5) ; it is apparently identical to an activity first described from human placenta (6) . DDB activity is associated with an =124-kDa polypeptide (3) (4) (5) , which is isolated complexed with a 41-kDa protein. This stable heterodimer can, in turn, form a higher order complex (5, 7) . The role of the DDB protein in nucleotide-excision repair is not known; indeed, there is as yet only indirect evidence that it is involved in DNA repair at all (8) (9) (10) (11) .
An obvious hypothesis is that a defect in DDB activity causes the DNA-repair defect in XP-E (2). However, when cells from other, unrelated XP-E patients were examined, only those from one additional XP-E individual were found to lack DDB activity, whereas cells from 12 other XP-E patients in 10 families showed normal levels of DDB activity that was indistinguishable from that of normal controls by several biochemical criteria (12) (13) (14) . Although the correlation between XP-E and a Ddb-cellular phenotype appears to be statistically significant when compared with the Ddb+ phenotype of all non-XP-E cells analyzed to date (13, 14) , the incomplete linkage raises doubts as to whether XP-E is caused by a defect in DDB activity. [ Microinjection and UDS Measurement. DDB protein was purified from HeLa cells as described (5) and then concentrated and desalted in a Centricon 10 microconcentrator (Amicon). Injected samples were in phosphate-buffered saline (PBS) containing 0.005% (vol/vol) Triton X-100 and bovine serum albumin at 2 mg/ml. DDB activity was assayed by nitrocellulose filter binding, as described (5 
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DDB activity traps one fmol of UV-induced lesions in this assay. A DDB concentration of 3 x 106 units/ml yields approximately one cell equivalent of DDB activity per injection (see below).
Homopolykaryons prepared by fusion of diploid fibroblasts were used for injection experiments to help ensure that the nuclei of injected cells were not in S phase (because the high level of replicative synthesis of S-phase cells would obscure the much lower levels of incorporation from DNArepair synthesis) and to provide multiple nuclei to score for DNA repair from each injection (20, 21) . Homopolykaryons show UDS characteristics indistinguishable from those of monokaryons (22) . Cell fusions were prepared by using heat-inactivated Sendai virus (23) or a 3-min treatment with 50%o (wt/vol) polyethylene glycol in culture medium lacking fetal bovine serum. Fused cells were seeded onto glass slides marked with a grid and incubated .3 days before injection without changing the medium.
Injection via glass microneedles was as described (20) (21) (22) (23) (24) .
After injection, cells were incubated up to 2 hr at 37C. UDS was then assayed essentially as described (23, 24 Fig. 2B ). DDB protein also corrected the DNA-repair defect in Ddbcells derived from another XP-E patient, XP82TO ( Table 1) . As with XP2RO cells, enhancement of UDS in this strain was =two-fold, and the distribution of autoradiographic graincount frequencies overlapped with the normal range (data not shown). (Fibroblasts from patient XP3RO, the third known Ddb-XP-E patient and a second cousin of patient XP2RO (25), were not available for testing.) These results provide direct evidence that a defect in DDB activity causes the repair defect in cells from a subset of XP-E patients, which in turn establishes that the DDB protein is involved in nucleotideexcision repair in vivo. Furthermore, these results rule out the possibility that the correlation between XP-E and defective DDB activity is due to a fortuitous genetic linkage between the DDB-encoding gene and the gene that, when defective, causes XP-E (13).
Correction of the DNA-repair defect is specific for XP-E. Within the variation inherent to UDS measurements, we never observed a significant stimulation of UDS upon injection of DDB protein into cells from each of the other excision-repair-defective XP groups or into cells from a patient with an excision-repair-defective form of trichothiodystrophy (16-18) ( The amount of DDB protein injected relative to the levels found in normal cells can be estimated by assuming an injected volume of =50 fl (20) and a normal DDB level of 150 Table 3 ), indicating that <10% of the normal amount ofDDB activity was sufficient for wild-type levels of DNA repair in this assay. Injection of increased amounts of DDB protein beyond the minimum necessary for full correction gave no further stimulation of repair, as expected for true correction of the XP-E defect. We also examined the ability of normal DDB protein to correct the DNA-repair defect in the Ddb+ class of XP-E cells. No effect on UDS was seen when DDB protein was injected into XP43TO or XP93TO fibroblasts under conditions that yielded correction of the DNA-repair defect in Ddb-cells (Table 1 ). The ability of DDB protein to stimulate DNA repair thus appears to be limited to the Ddb-class of XP-E cells in this assay.
DISCUSSION
Previous studies demonstrated that cells from some XP-E patients lack a DNA-binding activity specific for damaged DNA (2, 12, 13) , but these studies could not establish a causal relationship between the defect in DDB activity and the XP-E DNA-repair defect. To address this question, we tested whether microinjection of DDB protein purified from repairproficient cells could correct the DNA-repair defect in XP-E cells. Microinjection of purified DDB protein stimulated UV-induced DNA repair specifically in the Ddb-class of XP-E cells. This stimulation appears to be a bona fide correction of the XP-E defect based on the following observations. (i) Repair DNA synthesis was stimulated to wildtype levels, and injection of DDB protein levels above the amount required for full correction gave no further stimulation. (ii) Stimulation of repair was specific for cells from XP-E. These results thus provide direct evidence that the DNA-repair defect in the XP2RO and XP82TO strains is caused by the defect in DDB activity.
The original studies that identified the DDB activity were intended to define damage-recognition activities that function in DNA repair (2, 6) . However, there was only indirect evidence for a role of the DDB protein in DNA repair (8) (9) (10) (11) . Moreover, a high-mobility-group 1 protein recognizes damaged DNA and binds cisplatin adducts (26, 27 ). It appears to potentiate the lethal effects of platinum-DNA adducts, but not to be involved in the repair of these lesions (27) (28) (29) . The results presented here provide direct evidence that the DDB protein functions in nucleotide-excision repair in vivo. The role that the DDB protein plays in DNA repair remains in question. The mildness of the DNA-repair defect in XP-E (1) might suggest that the DDB protein functions in one of several parallel damage-processing pathways with overlapping specificities. Blocking one repair pathway by eliminating the DDB activity might only partially affect the sum total of DNA repair. Alternatively, the DDB protein might play an ancillary or stimulatory, rather than a central, role in DNAdamage recognition in nucleotide-excision repair. Binding by DDB protein might alter chromatin structure to facilitate access to DNA damage by other components of the DNArepair machinery, or DDB protein might help to recruit processing enzymes to the sites of DNA damage in a manner such as that for the photolyases of Escherichia coli and Saccharomyces cerevisiae, which stimulate DNA repair in the absence of photoreactivating light by interacting with the nucleotide-excision repair system (30, 31) . Such stimulatory or ancillary roles might be necessary to achieve maximally efficient or maximally rapid DNA repair but would not be absolutely required for repair to proceed.
One striking feature of the DDB protein is its abundancenearly 105 copies per cell (5) . This high number is surprising because the complete absence of DDB activity gives only a 50%6 reduction in DNA-repair capacity and, even more telling, introduction of <a10%t of the normal cellular amount results in normal DNA-repair levels in XP2RO cells. One interpretation of this abundance is that the DDB protein has another function in the cell aside from its role in DNA repair. Its relatively high affinity for undamaged DNA (7) raises the possibility that it may be a normal chromosomal constituent, although an unusual one because sequence analysis reveals no identity with known proteins (14, 32) .
The molecular basis of the DNA-repair defect in the Ddb+ of XP-E cells remains a puzzle. Two models can account for the Ddb+ phenotype seen in most XP-E strains [assuming that the individuals studied here are truly members of complementation group E, as was independently confirmed for XP93TO (see Materials and Methods)]. (i) Different XP-E patients may have defects at distinct genetic loci that fail to complement one another in cell-fusion experiments (13) . Such nonallelic noncomplementation could be the result of mutant and wild-type products of separate loci associating to form nonfunctional protein complexes, for example. The high-molecular-weight DDB protein complex and the heterodimeric structure of the core DDB protein (5, 14) provide obvious candidates for interacting gene products that, when mutated, might fail to cross-complement.
(ii) The protein present in the majority of XP-E strains could be altered at a domain other than its DNA-binding region (12, 13) . Because the protein has no observed enzymatic activity (3, 5, 6) , it presumably interacts with other proteins to mediate excision repair of target lesion(s). Mutations in domains involved in protein-protein interactions might allow DNA binding but not subsequent damageprocessing events. This model could account for the inability of the DDB protein to correct the repair defect in Ddb+ XP-E cells. For example, if the active form of the DDB protein in vivo is a higher order complex of the core heterodimer with other polypeptides, the accessory polypeptides in Ddb+ XP-E cells might be sequestered in nonfunctional complexes with a defective endogenous heterodimer, unable to associate with the injected normal protein. Resolution of this issue must await molecular analysis ofgenes for the DDB subunits expressed in XP-E cells.
